DEAR DR. ROACH: I’m a 75-year-old woman who, for at least 10 years now, has been experiencing a rapid heart rate. My blood ...
Hosted on MSN1d
HeartBeam submits 510(k) application to FDA for ECG softwareHeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback